Department Pulmonary Medicine
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations Specialties & Treatments

Specialty in Diseases & Conditions

  • Adult Cystic Fibrosis
  • Bronchiectasis
  • Non-Tuberculosis Mycobacteria (ASB)
  • Primary Ciliary Dysfunction
View all 4 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Elliot Dasenbrook, MD

Elliott Dasenbrook, MD MHS, is the Director of the Cleveland Clinic Adult Cystic Fibrosis Program and the Bronchiectasis Center in the Respiratory Institute.  Dr. Dasenbrook trained in the care of individuals living with cystic fibrosis at Johns Hopkins Hospital under the mentorship of Dr. Michael Boyle. Dr. Dasenbrook is known around the world for his expertise in the management of difficult to treat infections.  As a member of a multidisciplinary CF team at the Cleveland Clinic, Dr. Dasenbrook partners with his patients to meet their individual goals in order to optimize health outcomes.  He has been involved in the care of individuals with CF for more than 10 years and believes that the most important member of the CF team is the patient.

Dr. Dasenbrook is a member of the National Cystic Fibrosis Access to Care Committee which is comprised of patients, family members, and clinicians to identify barriers and solutions to improve access to care in the United States.   He alsoparticipates in Research and is the Associate Chair of the National CF Foundation Patient Registry Committee.

For more informationabout the Cleveland Clinic CF program or an appointment, please call 216.442.4623 (GOCF)

Dr. Dasenbrook has taken the skills he has learned in the care of cystic fibrosis lung disease and applied it to individuals with bronchiectasis and pulmonary nontuberculous mycobacteria (NTM) infectious such as Mycobacteriumavium complex (MAC) and Mycobacterium abscessus. The focus in this clinic is diagnosing the underlying cause of bronchiectasis (such as primary ciliary dyskinesia (PCD)) and expert management of bronchiectasis lung disease.

The goal of the clinic is to improve patient day to day quality of life through reduction of daily cough, mucus production,and number of respiratory exacerbations. To achieve these goals, the Bronchiectasis team at the Cleveland Clinic hasadvanced knowledge in airway clearance techniques and devices, inhaled medications to treat airway infections, and treatment of airway inflammation. For patients who have NTM, Dr.Dasenbrook collaborates with his colleagues from Infectious Disease who also specialize intreatment of pulmonary NTM. In addition to clinical care, Dr. Dasenbrook is active in research for non-CF bronchiectasis.

Education & Professional Highlights

Education & Professional Highlights

Appointed
2015

Education & Fellowships

Fellowship - Johns Hopkins University School of Medicine
Pulmonary & Critical Care Medicine
Baltimore, MD USA
2009

Residency - Loyola University Stritch School of Medicine
Internal Medicine
Chicago, IL USA
2005

Medical School - Loyola University Stritch School of Medicine
MD
Chicago, IL USA
2001

Undergraduate - Loyola University
Chicago, IL USA
1997

Certifications

  • Internal Medicine - Pulmonary Disease
  • Internal Medicine - Critical Care Medicine

Specialty Interests

Adult Cystic Fibrosis, Bronchiectasis, Nontuberculous Mycobacterial Pulmonary Disease, Primary Ciliary Dysfunction, and Allergic Bronchopulmonary Aspergillosis

Research & Publications

Research & Publications

See publications for Elliot Dasenbrook, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/15/2017, Dr. Dasenbrook has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Dasenbrook receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Gilead Sciences, Inc.
  • Vertex Pharmaceuticals Incorporated

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

79 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
4.9 out of 5
Explains 5
Listens 5
Courtesy, Respect & Concern 5
Knows Medical History 4.8
Time Spent with Patient 5
Patient Rating of Doctor 4.9

11 Patient Comments

Reviewed on Oct 2, 2017

The doctor did explain about my medical problems and my care with possible future changes. He did make both me and my husband feel alittle better about me situation. But at the same time did not mimimize the seriousness of my diagnosis.

Reviewed on Jun 6, 2017

very good

Reviewed on May 10, 2017

I had a question about my care after returning home, and Dr. Dasenbrook personally returned the call.

Reviewed on Apr 24, 2017

I felt he explained things very good so i could understand.

Reviewed on Mar 16, 2017

Dr. Dasenbrook is always very thorough and gives a wealth of useful information.

Reviewed on Mar 1, 2017

The only thing that's hard is having so many appointments in one day. but everyone at CC is mostly great and I really like and respect Dr Dasenbrook!

Reviewed on Jan 23, 2017

I had a better experience and got more help and answers on my 1st visit than I have in 4 months.

Reviewed on Jan 20, 2017

Excellent physician - listened patiently and well - diagnosed my condition - recommended treatment and follow up in April.

Reviewed on Jan 16, 2017

I had misunderstood some medical sleep apnea questions my last visit and he cleared that up for me. It was how I explained how I was feeling that I didn't express properly so it was nice to talk about that and get it cleared up. Thankful he mentioned it which showed he knew my history and was on top of it.

Reviewed on Jan 11, 2017

Dr. Dasenbrook is the best doctor I've seen! He is very polite and knowledgeable!

Reviewed on Dec 22, 2016

Dr. Dasenbrook has done a very good job of communicating details regarding my condition that are very complex and rare

Related Videos Featuring Elliot Dasenbrook, MD

Related Videos Featuring Elliot Dasenbrook, MD